| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Epidemiology [Q. W., M. L. B., Y. G., L. C., J. C.], Thoracic and Head and Neck Medical Oncology [L. M., Y. F.], Pathology [J. M. B.], and Neuro-Oncology [W. K. A. Y., V. A. L., A. P. K.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
Microsatellite instability (MIN) is frequently observed in hereditary nonpolyposis colon cancer and in other sporadic cancers including gliomas. Abnormalities in at least one of five mismatch repair (MMR) genes are implicated in the development of cancers in hereditary nonpolyposis colon cancer and the associated MIN. Using a newly developed multiplex reverse transcription-PCR assay, we evaluated the expression of the five known human MMR genes (hMSH2, hMLH1, hPMS1, hPMS2, and GTBP) in human gliomas by measuring simultaneously the relative levels of the transcripts. The ß-action gene was used as an internal control for RNA degradation and DNA contamination and as a reference for quantifying the levels of their transcripts. Of the 33 gliomas examined, 42% (14) had low expression of hMSH2 (at least 45-fold lower than normal mean), 21% (7) had low expression of hMLH1, and 18% (6) had low expression of hPMS1 compared with the expression in the lymphocytes from 13 normal individuals. Furthermore, six of the 33 (18%) tumor samples had decreased expression of more than one MMR gene. Two of these six patients with multiple gene abnormalities had second primary cancers, and an additional patient had multifocal gliomas. Further molecular analysis of available DNA samples indicated that one of five of those tumors with aberrant expression of MMR genes had MIN, as compared with none of five tumors with normal expression. These data suggest that reduced expression of MMR genes is frequent in human gliomas and that aberrant expression of more than one MMR gene may be associated with increased risk of second primary malignancies in glioma patients.
1 This work was supported in part by a grant from the Charlotte Geyer Foundation (to M. L. B.), by NIH Grants CA70242 and CA70334 (to Q. W.), CA 70917 (to M. L. B.) and CA 55261 (to V. A. L.), and by National Cancer Institute Core Grant CA16672 to M. D. Andeson Cancer Center.
2 To whom requests for reprints should be addressed, at Department of Epidemiology, Box 189, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. Phone: (713) 792-3020; Fax: (713) 792-0807; E-mail: qwei@request.mda.uth.tmc.edu.
Received 12/31/96. Accepted 3/20/97.
This article has been cited by other articles:
![]() |
L. Yang, M. J. Clarke, B. L. Carlson, A. C. Mladek, M. A. Schroeder, P. Decker, W. Wu, G. J. Kitange, P. T. Grogan, J. M. Goble, et al. PTEN Loss Does Not Predict for Response to RAD001 (Everolimus) in a Glioblastoma Orthotopic Xenograft Test Panel Clin. Cancer Res., June 15, 2008; 14(12): 3993 - 4001. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wrensch, T. Rice, R. Miike, A. McMillan, K. R. Lamborn, K. Aldape, and M. D. Prados Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area Neuro-oncol, January 1, 2006; 8(1): 12 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fukushima, Y. Katayama, T. Watanabe, A. Yoshino, A. Ogino, T. Ohta, and C. Komine Promoter Hypermethylation of Mismatch Repair Gene hMLH1 Predicts the Clinical Response of Malignant Astrocytomas to Nitrosourea Clin. Cancer Res., February 15, 2005; 11(4): 1539 - 1544. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nomoto, M. Maekawa, K. Sugano, M. Ushiama, N. Fukayama, S. Fujita, and T. Kakizoe Methylation Status and Expression of Human Telomerase Reverse Transcriptase mRNA in Relation to Hypermethylation of the p16 gene in Colorectal Cancers as Analyzed by Bisulfite PCR-SSCP Jpn. J. Clin. Oncol., January 1, 2002; 32(1): 3 - 8. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hanaoka, Y. Yamano, H. Hashimoto, J. Kagawa, and S. Tsugane A Preliminary Evaluation of Intra- and Interindividual Variations of hOGG1 Messenger RNA Levels in Peripheral Blood Cells as Determined by a Real-Time Polymerase Chain Reaction Technique Cancer Epidemiol. Biomarkers Prev., November 1, 2000; 9(11): 1255 - 1258. [Abstract] [Full Text] |
||||
![]() |
G. Xinarianos, T. Liloglou, W. Prime, P. Maloney, J. Callaghan, P. Fielding, J. R. Gosney, and J. K. Field hMLH1 and hMSH2 Expression Correlates with Allelic Imbalance on Chromosome 3p in Non-Small Cell Lung Carcinomas Cancer Res., August 1, 2000; 60(15): 4216 - 4221. [Abstract] [Full Text] |
||||
![]() |
I. U. Ali, L. M. Schriml, and M. Dean Mutational Spectra of PTEN/MMAC1 Gene: a Tumor Suppressor With Lipid Phosphatase Activity J Natl Cancer Inst, November 17, 1999; 91(22): 1922 - 1932. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cheng, Y. Guan, L. Li, R. J. Legerski, J. Einspahr, J. Bangert, D. S. Alberts, and Q. Wei Expression in Normal Human Tissues of Five Nucleotide Excision Repair Genes Measured Simultaneously by Multiplex Reverse Transcription-Polymerase Chain Reaction Cancer Epidemiol. Biomarkers Prev., September 1, 1999; 8(9): 801 - 807. [Abstract] [Full Text] |
||||
![]() |
E. M. Sturgis, G. L. Clayman, Y. Guan, Z. Guo, and Q. Wei DNA Repair in Lymphoblastoid Cell Lines From Patients With Head and Neck Cancer Arch Otolaryngol Head Neck Surg, February 1, 1999; 125(2): 185 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Chang, L. Ricciardiello, A. Goel, C. L. Chang, and C. R. Boland Steady-state Regulation of the Human DNA Mismatch Repair System J. Biol. Chem., June 9, 2000; 275(24): 18424 - 18431. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |